The rationale for Sig1R agonist or antagonist experiments is based on the presumption that pretreatment of these drugs prior to cocaine exposure at (1,3,6,9 days post-infection) is more effective to block the action of cocaine on CATB secretion and HIV-1 infection. Here, SIGMAR1 is linked to infection.